RALLYBIO CORPORATION Payments to Acquire Equity Method Investments
RALLYBIO CORPORATION (RLYB) reported Payments to Acquire Equity Method Investments of $300.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireEquityMethodInvestments · last filed 2022-11-07
- RALLYBIO CORPORATION payments to acquire equity method investments for the quarter ending 2022-09-30 was $100.00K.
- RALLYBIO CORPORATION payments to acquire equity method investments for the quarter ending 2022-06-30 was $200.00K, a 86.67% decline year-over-year.
- RALLYBIO CORPORATION payments to acquire equity method investments for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- RALLYBIO CORPORATION payments to acquire equity method investments for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- RALLYBIO CORPORATION payments to acquire equity method investments for fiscal 2021 was $2.00M, a 5.26% increase from fiscal 2020.
- RALLYBIO CORPORATION payments to acquire equity method investments for fiscal 2020 was $1.90M.
| Period end | Payments to Acquire Equity Method Investments 3 month | Payments to Acquire Equity Method Investments 6 month | Payments to Acquire Equity Method Investments 9 month | Payments to Acquire Equity Method Investments 12 month |
|---|---|---|---|---|
| 2022-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $300.00K derived: sum of 2 quarters · filed 2022-11-07 | $300.00K 10-Q · filed 2022-11-07 | $300.00K derived: sum of 4 quarters · filed 2022-11-07 |
| 2022-06-30 | $200.00K 10-Q · filed 2022-08-08 | $200.00K 10-Q · filed 2022-08-08 | $200.00K derived: sum of 3 quarters · filed 2022-08-08 | $200.00K derived: sum of 4 quarters · filed 2022-11-07 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | $0.00 derived: sum of 2 quarters · filed 2022-05-10 | $0.00 derived: sum of 3 quarters · filed 2022-11-07 | $1.50M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $0.00 derived: sum of 2 quarters · filed 2022-11-07 | $1.50M derived: sum of 3 quarters · filed 2022-11-07 | $2.00M 10-K · filed 2022-03-15 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $1.50M derived: sum of 2 quarters · filed 2022-11-07 | $2.00M 10-Q · filed 2022-11-07 | $2.30M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $1.50M 10-Q · filed 2022-08-08 | $2.00M 10-Q · filed 2022-08-08 | $2.30M derived: sum of 3 quarters · filed 2022-08-08 | $2.30M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $500.00K 10-Q · filed 2022-05-10 | $800.00K derived: sum of 2 quarters · filed 2022-05-10 | $800.00K derived: sum of 3 quarters · filed 2022-05-10 | $1.80M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $300.00K derived: sum of 2 quarters · filed 2022-03-15 | $1.30M derived: sum of 3 quarters · filed 2022-03-15 | $1.90M 10-K · filed 2022-03-15 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.00M derived: sum of 2 quarters · filed 2021-11-10 | $1.60M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $1.00M 10-Q · filed 2021-09-09 | $1.60M 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |